AND	term1 AND term2	Both terms must be included
OR	term1 OR term2	Either term
NOT	term1 NOT term2	term2 must not appear
""	"term1 term2"	Exact match
()	term1 AND (term2 OR term3)	Grouping terms
?	withdr?w	Single letter wildcard (withdraw, withdrew)
*	withdr*	Multiple letter wildcard (withdraw, withdrawn, withdrawing)
"..."~n	"term1 term2"~n	Proximity (term1 within n words of term2)

Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results:1-10 of 476

CADTH releases new guidelines

Smart & Biggar/Fetherstonhaugh
Canada
September 19 2018

The Canadian Agency for Drugs and Technologies in Health (CADTH) recently published the Procedure and Submission Guidelines for the CADTH Common Drug

You don’t need to build it for them to come: Federal Court affirms trademark “use” for services does not require bricks and mortar business in Canada

Smart & Biggar/Fetherstonhaugh
Canada
September 13 2018

Non-Canadian hoteliers have reason for celebration following the release of the Federal Court of Canada’s anticipated decision in Hilton Worldwide

Patented Medicine Prices Review Board releases annual report on drug market entry

Smart & Biggar/Fetherstonhaugh
Canada
September 12 2018

The Patented Medicine Prices Review Board recently announced the publication of the second annual edition of Meds Entry Watch 2016. The report

Patented Medicine Prices Review Board's multi-stakeholder steering committee holds first meeting

Smart & Biggar/Fetherstonhaugh
Canada
September 12 2018

The Patented Medicine Prices Review Board (PMPRB) has been consulting on its proposed reform of the federal price review process and associated

Alexion denied leave to appeal in case challenging constitutionality of PMPRB's remedial powers

Smart & Biggar/Fetherstonhaugh
Canada
September 10 2018

The Supreme Court of Canada recently dismissed Alexion Pharmaceuticals' application for leave to appeal the Federal Court of Appeal decision in

Shire's VYVANSE patent valid, prohibition order issued

Smart & Biggar/Fetherstonhaugh
Canada
September 3 2018

The Federal Court has granted Shire's application under the pre-amended Patented Medicines (Notice of Compliance) Regulations for an order prohibiting

Federal Court of Appeal dismisses Apotex’s appeal in judicial review of Health Canada decision seeking further information from facilities in India

Smart & Biggar/Fetherstonhaugh
Canada
August 29 2018

As previously reported, the Federal Court dismissed Apotex's application for judicial review of the decision of the Therapeutic Products Directorate

Patented Medicine Prices Review Board releases August 2018 NEWSletter

Smart & Biggar/Fetherstonhaugh
Canada
August 29 2018

The Patented Medicine Prices Review Board (PMPRB) released the August 2018 issue of its NEWSletter which includes an update on the PMPRB's

CADTH launches the CADTH Pharmaceutical Reviews Update

Smart & Biggar/Fetherstonhaugh
Canada
August 29 2018

The Canadian Agency for Drugs and Technologies in Health (CADTH) has launched the CADTH Pharmaceutical Reviews Update

Health Canada to implement further pre-market transparency initiatives for prescription drugs

Smart & Biggar/Fetherstonhaugh
Canada
August 29 2018

Health Canada announced it will move forward with Phase III of its prescription drug product transparency initiatives. Beginning October 1

Search techniques

Current Search

Refine

Content type

Tags